About me
Ellie Froslan is an undergraduate student at the University of Southern California pursuing a B.S. in Biopharmaceutical Sciences with a minor in Consumer Behavior, alongside a progressive M.S. in Healthcare Decision Analysis. She is a student researcher at the D.K. Kim International Center for Regulatory Science, focusing on regulatory strategy, clinical development, and FDA/EMA frameworks. Her interests include neuropsychiatric drug development, pharmacogenomics, and improving equity in clinical trials. She is particularly interested in translating scientific innovation into real-world impact at the intersection of biopharma, commercialization, and product strategy, with a focus on bringing innovative therapies to market.
